'Metabolically healthy obesity': Origins and implications

Molecular Aspects of Medicine

Volumn 34, Issue 1, 2013, Pages 59-70

  Denis, Gerald V ^a   Obin, Martin S ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

adipose tissue macrophage; AIM; apoptosis inhibitor of macrophage; ATM; BMI; body mass index; cardiovascular disease; CLS; crown like structure; CVD; ECM; extracellular matrix; HOMA; homeostasis model assessment; IBD; IL; inflammatory bowel disease; insulin resistance; interleukin; IR; major histocompatibility complex; metabolic syndrome; metabolically healthy obese; metabolically obese normal weight; MHC; MHO; MONW; MS; PCOS; peroxisome proliferator activated receptor; polycystic ovary syndrome; PPAR; RA; rheumatoid arthritis; T2D; TBP; thiazolidinedione; thioredoxin binding protein; TNF; TPL2; tumor necrosis factor; tumor progression locus 2; Type 2 diabetes; TZD; WAT; white adipose tissue

Indexed keywords

ADIPONECTIN; APOPTOSIS INHIBITOR OF MACROPHAGE PROTEIN; COLLAGEN TYPE 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REGULATOR PROTEIN; REPRESSOR PROTEIN; THIOREDOXIN INTERACTING PROTEIN; TUMOR PROGRESSION LOCUS 2 PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; BODY WEIGHT; BRD2 GENE; CELL STRESS; CHROMATIN; CHRONIC INFLAMMATION; CLINICAL FEATURE; COMPLEX FORMATION; EXPERIMENTAL MODEL; FIBROSIS; GENE EXPRESSION; HUMAN; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 GENE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLIC DISORDER; NONHUMAN; OBESITY; PHENOTYPE; REVIEW; RISK ASSESSMENT; TRANSGENIC MOUSE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EXERCISE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICE; OBESITY;

EID: 84872131467     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2012.10.004     Document Type: Review

References (120)

1. C.A. Aguilar-Salinas, E.G. García, L. Robles, D. Riaño, D.G. Ruiz-Gomez, A.C. García-Ulloa, M.A. Melgarejo, M. Zamora, L.E. Guillen-Pineda, R. Mehta, S. Canizales-Quinteros, M.T. Tusie Luna, and F.J. Gómez-Pérez High adiponectin concentrations are associated with the metabolically healthy obese phenotype J. Clin. Endocrinol. Metab. 93 2008 4075 4079
2. J.P. Bastard, M. Maachi, C. Lagathu, M.J. Kim, and M. Caron Recent advances in the relationship between obesity, inflammation, and insulin resistance Eur. Cytokine Netw. 17 2006 4 12
3. A.C. Belkina, W. Blanton, F. Wang, H. Liu, and G.V. Denis Whole body Brd2 deficiency protects obese mice from insulin resistance by creating a low inflammatory environment Obesity 18 2010 S58
4. A.C. Belkina, and G.V. Denis Obesity genes and insulin resistance Curr. Opin. Endocrinol. Diabetes Obes. 17 2010 472 477
5. A.C. Belkina, and G.V. Denis BET domain co-regulators in obesity, inflammation and cancer Nat. Rev. Cancer 12 2012 465 477
6. A.H. Berg, and P.E. Scherer Adipose tissue, inflammation, and cardiovascular disease Circ. Res. 96 2005 939 949 (Pubitemid 40712793)
7. R.N. Bergman, S.P. Kim, K.J. Catalano, I.R. Hsu, J.D. Chiu, M. Kabir, K. Hucking, and M. Ader Why visceral fat is bad: mechanisms of the metabolic syndrome Obesity (Silver Spring) 14 Suppl. 1 2006 16S 19S
8. M. Blüher Adipose tissue dysfunction in obesity Exp. Clin. Endocrinol. Diabetes 117 2009 241 250
9. M. Blüher The distinction of metabolically 'healthy' from 'unhealthy' obese individuals Curr. Opin. Lipidol. 21 2010 38 43
10. M. Blüher Are there still healthy obese patients? Curr. Opin. Endocrinol. Diabetes Obes. 19 2012 341 346
11. E. Bonora, J. Willeit, S. Kiechl, F. Oberhollenzer, G. Egger, R. Bonadonna, and M. Muggeo U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck study. Diabetes Care 21 1991 221 230
12. C. Bouchard, A. Tremblay, J.P. Després, A. Nadeau, P.J. Lupien, G. Thériault, J. Dussault, S. Moorjani, S. Pinault, and G. Fournier The response to long-term overfeeding in identical twins N. Engl. J. Med. 322 1990 1477 1482 (Pubitemid 20179860)
13. G. Calori, G. Lattuada, L. Piemonti, M.P. Garancini, F. Ragogna, M. Villa, S. Mannino, P. Crosignani, E. Bosi, L. Luzi, G. Ruotolo, and G. Perseghin Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona study Diabetes Care 34 2011 210 215
14. J. Chen, S.T. Hui, F.M. Couto, I.N. Mungrue, D.B. Davis, A.D. Attie, A.J. Lusis, R.A. Davis, and A. Shalev Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes FASEB J. 22 2008 3581 3594
15. T.H. Chun, K.B. Hotary, F. Sabeh, A.R. Saltiel, E.D. Allen, and S.J. Weiss A pericellular collagenase directs the 3-dimensional development of white adipose tissue Cell 125 2006 577 591
16. W.A. Chutkow, A.L. Birkenfeld, J.D. Brown, H.Y. Lee, D.W. Frederick, J. Yoshioka, P. Patwari, R. Kursawe, S.W. Cushman, J. Plutzky, G.I. Shulman, V.T. Samuel, and R.T. Lee Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity Diabetes 59 6 2010 1424 1434
17. W.A. Chutkow, and R.T. Lee Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability J. Biol. Chem. 286 2011 29139 29145
18. S. Cinti, G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, A.S. Greenberg, and M.S. Obin Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J. Lipid Res. 46 2005 2347 2355 (Pubitemid 41532523)
19. J.A. Colwell Multifactorial aspects of the treatment of the type II diabetic patient Metabolism 46 12 Suppl. 1 1997 1 4
20. T.P. Combs, U.B. Pajvani, A.H. Berg, Y. Lin, L.A. Jelicks, M. Laplante, A.R. Nawrocki, M.W. Rajala, A.F. Parlow, L. Cheeseboro, Y.Y. Ding, R.G. Russell, D. Lindemann, A. Hartley, G.R. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, and P.E. Scherer A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity Endocrinology 145 2004 367 383 (Pubitemid 38094532)
21. M. Côté, P. Mauriège, J. Bergeron, N. Alméras, A. Tremblay, I. Lemieux, and J.P. Després Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men J. Clin. Endocrinol. Metab. 90 2005 1434 1439
22. P.I. de Bakker, G. McVean, P.C. Sabeti, M.M. Miretti, T. Green, J. Marchini, X. Ke, A.J. Monsuur, P. Whittaker, M. Delgado, J. Morrison, A. Richardson, E.C. Walsh, X. Gao, L. Galver, J. Hart, D.A. Hafler, M. Pericak-Vance, J.A. Todd, and M.J. Daly A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC Nat. Genet. 38 2006 1166 1172 (Pubitemid 44470362)
23. G.V. Denis Bromodomain coactivators in cancer, obesity, Type 2 diabetes, and inflammation Discovery Med. 10 2010 489 499
24. G.V. Denis, B.S. Nikolajczyk, and G.R. Schnitzler An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis FEBS Lett. 584 2010 3260 3268
25. G.V. Denis, and D.J. Bowen Uncoupling obesity from cancer: bromodomain co-regulators that control networks of inflammatory genes A.J. Dannenberg, N.A. Berger, Energy Balance and Cancer Obesity, Inflammation and Cancer vol. 7 2013 Springer New York (Expected 2013)
26. J.-P. Després, A. Nadeau, A. Tremblay, M. Ferland, S. Moorjani, P.J. Lupien, G. Thériault, S. Pinault, and C. Bouchard Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women Diabetes 38 1989 304 309 (Pubitemid 19071468)
27. J.-P. Després, S. Moorjani, P.J. Lupien, A. Tremblay, A. Nadeau, and C. Bouchard Genetic aspects of susceptibility to obesity and related dyslipidemias Mol. Cell. Biochem. 113 1992 151 169
28. A. Divoux, J. Tordjman, D. Lacasa, N. Veyrie, D. Hugol, and A. Aissat Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss Diabetes 59 2010 2817 2825
29. R.P. Donahue, R.D. Abbott, E. Bloom, D.M. Reed, and K. Yano Central obesity and coronary heart disease in men Lancet 1 1987 821 824
30. S.G. Dubois, L.K. Heilbronn, S.R. Smith, J.B. Albu, D.E. Kelley, and E. Ravussin Look AHEAD Adipose Research Group, Decreased expression of adipogenic genes in obese subjects with type 2 diabetes Obesity (Silver Spring) 1 2006 1543 1552 (Pubitemid 46214821)
31. W. Ebstein, and J. Muller Weitere mitteillungen uber die behandlung des diabetes mellitus mot carbisaure nebst bemerkunger uber die anwendung der salicylsaure bie dieser krankheit Berl. Klin. Wochenschr. 13 1876 53 56
32. M.M. Finucane, G.A. Stevens, M.J. Cowan, G. Danaei, J.K. Lin, C.J. Paciorek, G.M. Singh, H.R. Gutierrez, Y. Lu, A.N. Bahalim, F. Farzadfar, L.M. Riley, and M. Ezzati Global burden of metabolic risk factors of chronic diseases collaborating group (body mass index). National, regional, and global trends in body-s index since 1980 systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants Lancet 377 2011 557 567
33. S. Fujioka, Y. Matsuzawa, K. Tokunaga, and S. Tarui Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity Metabolism 36 1987 54 59 (Pubitemid 17016386)
34. M.O. Goodarzi, D.A. Dumesic, G. Chazenbalk, and R. Azziz Polycystic ovary syndrome: etiology, pathogenesis and diagnosis Nat. Rev. Endocrinol. 7 2011 219 231
35. S.F. Grant, and H. Hakonarson Genome-wide association studies in type 1 diabetes Curr. Diabetes Rep. 9 2009 157 163
36. R.J. Greenwald, J.R. Tumang, A. Sinha, N. Currier, R.D. Cardiff, T.L. Rothstein, D.V. Faller, and G.V. Denis Eμ-BRD2 transgenic mice develop B cell lymphoma and leukemia Blood 103 2004 1475 1484 (Pubitemid 38168665)
37. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, and F. Costa American Heart Association, diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752 Erratum in: Circulation 112, e297-e298 (Pubitemid 41532612)
38. D.P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C.L. Birmingham, and A.H. Anis The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis BMC Public Health 9 2009 88
39. N. Halberg, T. Khan, M.E. Trujillo, I. Wernstedt-Asterholm, A.D. Attie, S. Sherwani, Z.V. Wang, S. Landskroner-Eiger, S. Dineen, U.J. Magalang, R.A. Brekken, and P.E. Scherer Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue Mol. Cell. Biol. 29 2009 4467 4483
40. L. Handunnetthi, S.V. Ramagopalan, G.C. Ebers, and J.C. Knight Regulation of major histocompatibility complex class II gene expression, genetic variation and disease Genes Immun. 11 2010 99 112
41. D.W. Haslam, and W.P. James Obesity Lancet 366 2009 1197 1209 (Pubitemid 41393598)
42. C. Henegar, J. Tordjman, V. Achard, D. Lacasa, I. Cremer, M. Guerre-Millo, C. Poitou, A. Basdevant, V. Stich, N. Viguerie, D. Langin, P. Bedossa, J.D. Zucker, and K. Clement Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity Genome Biol. 9 2008 R14
43. W.L. Holland, R.A. Miller, Z.V. Wang, K. Sun, B.M. Barth, H.H. Bui, K.E. Davis, B.T. Bikman, N. Halberg, J.M. Rutkowski, M.R. Wade, V.M. Tenorio, M.S. Kuo, J.T. Brozinick, B.B. Zhang, M.J. Birnbaum, S.A. Summers, and P.E. Scherer Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin Nat. Med. 17 1 2011 55 63
44. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
45. Y. Huang, X. Yan, M.J. Zhu, R.J. McCormick, S.P. Ford, P.W. Nathanielsz, and M. Du Enhanced transforming growth factor-beta signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation Am. J. Physiol. Endocrinol. Metab. 298 2010 E1254 E1260
46. 2+ and AMPK/SIRT1 Nature 464 2010 1313 1319
47. S. Sawcer Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. International multiple sclerosis genetics consortium; wellcome trust case control consortium 2 Nature 476 2011 214 219
48. P.M. Janiszewski, and R. Ross Effects of weight loss among metabolically healthy obese men and women Diabetes Care 33 2010 1957 1959
49. S.E. Kahn, B. Zinman, S.M. Haffner, M.C. O'Neill, B.G. Kravitz, D. Yu, M.I. Freed, W.H. Herman, R.R. Holman, N.P. Jones, J.M. Lachin, and G.C. Viberti Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes Diabetes 55 2006 2357 2364 (ADOPT Study Group) (Pubitemid 44743635)
50. A.D. Karelis, M. Faraj, J.P. Bastard, D.H. St-Pierre, M. Brochu, D. Prud'homme, and R. Rabasa-Lhoret The metabolically healthy but obese individual presents a favorable inflammation profile J. Clin. Endocrinol. Metab. 90 2005 4145 4150 (Pubitemid 41058189)
51. M. Keophiphath, V. Achard, C. Henegar, C. Rouault, K. Clément, and D. Lacasa Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes Mol. Endocrinol. 23 2009 11 24
52. T. Khan, E.S. Muise, P. Iyengar, Z.V. Wang, M. Chandalia, N. Abate, B.B. Zhang, P. Bonaldo, S. Chua, and P.E. Scherer Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI Mol. Cell. Biol. 29 2009 1575 1591
53. C.S. Kim, H.S. Park, T. Kawada, J.H. Kim, D. Lim, N.E. Hubbard, B.S. Kwon, K.L. Erickson, and R. Yu Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters Int. J. Obes. (London) 30 2006 1347 1355 (Pubitemid 44306516)
54. J.Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M.E. Trujillo, S.M. Hofmann, T. Schraw, J.L. Durand, H. Li, G. Li, L.A. Jelicks, M.F. Mehler, D.Y. Hui, Y. Deshaies, G.I. Shulman, G.J. Schwartz, and P.E. Scherer Obesity-associated improvements in metabolic profile through expansion of adipose tissue J. Clin. Investig. 117 2007 2621 2637 (Pubitemid 47494363)
55. S.H. Kim, and G.M. Reaven Insulin resistance and hyperinsulinemia: you can't have one without the other Diabetes Care 31 2008 1433 1438
56. U. Kintscher, M. Hartge, K. Hess, A. Foryst-Ludwig, M. Clemenz, M. Wabitsch, P. Fischer-Posovszky, T.F. Barth, D. Dragun, T. Skurk, H. Hauner, M. Blüher, T. Unger, A.M. Wolf, U. Knippschild, V. Hombach, and N. Marx T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance Arterioscler. Thromb. Vasc. Biol. 28 2008 1304 1310
57. N. Klöting, M. Fasshauer, A. Dietrich, P. Kovacs, M.R. Schön, M. Kern, M. Stumvoll, and M. Blüher Insulin-sensitive obesity Am. J. Physiol. Endocrinol. Metab. 299 2010 E506 E515
58. J. Kurokawa, S. Arai, K. Nakashima, H. Nagano, A. Nishijima, K. Miyata, R. Ose, M. Mori, N. Kubota, T. Kadowaki, Y. Oike, H. Koga, M. Febbraio, T. Iwanaga, and T. Miyazaki Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity Cell Metab. 11 2010 479 492
59. J. Kurokawa, H. Nagano, O. Ohara, N. Kubota, T. Kadowaki, S. Arai, and T. Miyazaki Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue Proc. Natl. Acad. Sci. USA 108 2011 12072 12077
60. L. Lapidus, C. Bengtsson, B. Larsson, K. Pennert, E. Rybo, and L. Sjöström Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow-up of participants in the population study of women in Gothenburg Sweden. Br. Med. J. (Clin. Res. Ed.) 289 1984 1257 1261 (Pubitemid 15217605)
61. K. Lee Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors Asia Pac. J. Clin. Nutr. 18 2009 280 284
62. I. Lemieux, A. Pascot, D. Prud'homme, N. Alméras, P. Bogaty, A. Nadeau, J. Bergeron, and J.P. Després Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity Arterioscler. Thromb. Vasc. Biol. 21 2001 961 967 (Pubitemid 34168653)
63. G. Liu, M. Grifman, J. Macdonald, P. Moller, F. Wong-Staal, and Q.X. Li Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase J. Endocrinol. 194 2007 569 578 (Pubitemid 47471225)
64. M. Liu, R. Xiang, S.A. Wilk, N. Zhang, L.B. Sloane, K. Azarnoush, L. Zhou, H. Chen, G. Xiang, C.A. Walter, S.N. Austad, N. Musi, R.A. Defronzo, R. Asmis, P.E. Scherer, L.Q. Dong, and F. Liu Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance Diabetes 2012 [Epub ahead of print]
65. H. Mahdi, B.A. Fisher, H. Källberg, D. Plant, V. Malmström, J. Rönnelid, P. Charles, B. Ding, L. Alfredsson, L. Padyukov, D.P. Symmons, P.J. Venables, L. Klareskog, and K. Lundberg Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis Nat. Genet. 41 2009 1319 1324
66. A. Malhotra, S. Kobes, W.C. Knowler, L.J. Baier, C. Bogardus, and R.L. Hanson A genome-wide association study of BMI in American Indians Obesity (Silver Spring) 19 2011 2102 2106
67. H. Mangge, G. Almer, M. Truschnig-Wilders, A. Schmidt, R. Gasser, and D. Fuchs Inflammation, adiponectin, obesity and cardiovascular risk Curr. Med. Chem. 17 2010 4511 4520
68. Y. Matsuzawa Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience Diabetes Metab. Rev. 13 1997 3 13 (Pubitemid 27213790)
69. Y. Matsuzawa Therapy insight: Adipocytokines in metabolic syndrome and related cardiovascular disease Nat. Clin. Pract. Cardiovasc. Med. 3 2006 35 42 (Pubitemid 43078211)
70. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
71. J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan, and R.B. D'Agostino Body mass index, metabolic syndrome, and risk of Type 2 diabetes or cardiovascular disease J. Clin. Endocrinol. Metab. 91 2006 2906 2912 (Pubitemid 44271734)
72. T. Miyazaki, J. Kurokawa, and S. Arai AIMing at metabolic syndrome. Towards the development of novel therapies for metabolic diseases via apoptosis inhibitor of macrophage (AIM) Circ. J. 75 2011 2522 2531
73. Y. Muller, M. Abdussamad, R. Hanson, W.C. Knowler, C. Bogardus, and L. Baier Variants in/near BRD2 are associated with body mass index in Pima Indians Diabetes 60 Suppl. 1 2011 A1400
74. B.S. Nikolajczyk, M. Jagannathan-Bogdan, and G.V. Denis The outliers become a stampede as immunometabolism reaches a tipping point Immunol. Rev. 249 2012 253 275
75. J. O'Connell, L. Lynch, A. Hogan, T.J. Cawood, and D. O'Shea Preadipocyte factor-1 is associated with metabolic profile in severe obesity J. Clin. Endocrinol. Metab. 96 2011 E680 E684
76. H. Oflaz, N. Ozbey, F. Mantar, H. Genchellac, F. Mercanoglu, E. Sencer, S. Molvalilar, and Y. Orhan Determination of endothelial function and early atherosclerotic changes in healthy obese women Diabetes Nutr. Metab. 16 2003 176 181 (Pubitemid 37406819)
77. K. Ohashi, J.L. Parker, N. Ouchi, A. Higuchi, J.A. Vita, N. Gokce, A. Amstrup Pedersen, C. Kalthoff, S. Tullin, A. Sams, R. Summer, and K. Walsh Adiponectin promotes macrophage polarization towards an anti-inflammatory phenotype J. Biol. Chem. 285 2010 6153 6160
78. K. Ozaki, Y. Ohnishi, A. Iida, A. Sekine, R. Yamada, T. Tsunoda, H. Sato, H. Sato, M. Hori, Y. Nakamura, and T. Tanaka Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction Nat. Genet. 32 2002 650 654 (Pubitemid 35435179)
79. M. Ozgen, S.S. Koca, N. Dagli, M. Balin, B. Ustundag, and A. Isik Serum adiponectin and vaspin levels in rheumatoid arthritis Arch. Med. Res. 41 2010 457 463
80. M. Pasarica, B. Gowronska-Kozak, D. Burk, I. Remedios, D. Hymel, J. Gimble, E. Ravussin, G.A. Bray, and S.R. Smith Adipose tissue collagen VI in obesity J. Clin. Endocrinol. Metab. 94 2009 5155 5162
81. M.E. Patti, A.J. Butte, S. Crunkhorn, K. Cusi, R. Berria, S. Kashyap, Y. Miyazaki, I. Kohane, M. Costello, R. Saccone, E.J. Landaker, A.B. Goldfine, E. Mun, R. DeFronzo, J. Finlayson, C.R. Kahn, and L.J. Mandarino Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1 Proc. Natl. Acad. Sci. USA 100 2003 8466 8471 (Pubitemid 36842568)
82. R. Pear Obesity surgery often leads to complications, study says 2006 New York Times July 24
83. J.W. Perfield III, Y. Lee, G.I. Shulman, V.T. Samuel, M.J. Jurczak, E. Chang, C. Xie, P.N. Tsichlis, M.S. Obin, and A.S. Greenberg Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance Diabetes 60 2011 1168 1176
84. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737 (Pubitemid 38489895)
85. M.-C. Pouliot, J.-P. Després, A. Nadeau, S. Moorjani, D. Prud'Homme, P.J. Lupien, A. Tremblay, and C. Bouchard Visceral obesity in men. Associations with glucose tolerance, plasma insulin and lipoprotein levels Diabetes 41 1992 826 834
86. E.D. Rosen, P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, D.S. Milstone, B.M. Spiegelman, and R.M. Mortensen PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro Mol. Cell 4 1999 611 617 (Pubitemid 29531140)
87. E.D. Rosen, C.J. Walkey, P. Puigserver, and B.M. Spiegelman Transcriptional regulation of adipogenesis Genes Dev. 14 2000 1293 1307 (Pubitemid 30397073)
88. N.B. Ruderman, S.H. Schneider, and P. Berchtold The "metabolically- obese", normal-weight individual Am. J. Clin. Nutr. 34 1981 1617 1621
89. N.B. Ruderman, P. Berchtold, and S.H. Schneider Obesity associated disorders in normal weight individuals: some speculations Int. J. Obes. 6 Suppl. 1 1982 151 157 (Pubitemid 12064634)
90. N. Ruderman, D. Chisholm, X. Pi-Sunyer, and S. Schneider The metabolically obese, normal-weight individual revisited Diabetes 47 1998 699 713 (Pubitemid 28201798)
91. H.P. Santry, D.L. Gillen, and D.S. Lauderdale Trends in bariatric surgical procedures JAMA 294 2005 1909 1917 (Pubitemid 41464692)
92. M.E. Shaul, G. Bennett, K.J. Strissel, A.S. Greenberg, and M.S. Obin Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high fat diet-induced obesity in mice Diabetes 59 5 2010 1171 1181
93. S.E. Shoelson, J. Lee, and A.B. Goldfine Inflammation and insulin resistance J. Clin. Invest. 116 2006 179 1801
94. E.A.H. Sims Are there persons who are obese, but metabolically healthy? Metabolism 50 2001 1499 1504 (Pubitemid 34007425)
95. A. Sinha, D.V. Faller, and G.V. Denis Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A Biochem. J. 387 2005 257 269 (Pubitemid 40524096)
96. T. Skurk, C. Alberti-Huber, C. Herder, and H. Hauner Relationship between adipocyte size and adipokine expression and secretion J. Clin. Endocrinol. Metab. 92 2007 1023 1033 (Pubitemid 46465679)
97. K.L. Spalding, E. Arner, P.O. Westermark, S. Bernard, B.A. Buchholz, O. Bergmann, L. Blomqvist, J. Hoffstedt, E. Näslund, T. Britton, H. Concha, M. Hassan, M. Rydén, J. Frisén, and P. Arner Dynamics of fat cell turnover in humans Nature 453 2008 783 787 (Pubitemid 351793777)
98. M. Spencer, A. Yao-Borengasser, R. Unal, N. Rasouli, C.M. Gurley, B. Zhu, C.A. Peterson, and P.A. Kern Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation Am. J. Physiol. Endocrinol. Metab. 299 2010 E1016 E1027
99. E. Succurro, M.A. Marini, S. Frontoni, M.L. Hribal, F. Andreozzi, R. Lauro, F. Perticone, and G. Sesti Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals Obesity (Silver Spring) 16 2008 1881 1886
100. C.Y. Tan, and A. Vidal-Puig Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese Biochem. Soc. Trans. 36 2008 935 940
101. I. Tarkun, B.C. Arslan, Z. Cantürk, E. Türemen, T. Sahin, and C. Duman Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation J. Clin. Endocrinol. Metab. 89 2004 5592 5596 (Pubitemid 39518445)
102. P. Tontonoz, and B.M. Spiegelman Fat and beyond: the diverse biology of PPARgamma Ann. Rev. Biochem. 77 2008 289 312
103. K.A. Toulis, D.G. Goulis, D. Farmakiotis, N.A. Georgopoulos, I. Katsikis, B.C. Tarlatzis, I. Papadimas, and D. Panidis Adiponectin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis Hum. Reprod. Update 15 2009 297 307
104. P. Trayhurn, B. Wang, and I.S. Wood Hypoxia in adipose tissue: A basis for the dysregulation of tissue function in obesity? Br. J. Nutr. 100 2008 227 235
105. O. Tsukamoto, M. Fujita, M. Kato, S. Yamazaki, Y. Asano, A. Ogai, H. Okazaki, M. Asai, Y. Nagamachi, N. Maeda, Y. Shintani, T. Minamino, M. Asakura, I. Kishimoto, T. Funahashi, H. Tomoike, and M. Kitakaze Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure J. Am. Coll. Cardiol. 53 2009 2070 2077
106. J. Vague La différentiation sexuelle, facteur déterminant des formes de l'obésité Presse Méd. 55 1947 339 340
107. L.F. Van Gaal, I.L. Mertens, and C.E. De Block Mechanisms linking obesity with cardiovascular disease Nature 444 2006 875 880 (Pubitemid 46028447)
108. M. Vougioukalaki, D.C. Kanellis, K. Gkouskou, and A.G. Eliopoulos Tpl2 kinase signal transduction in inflammation and cancer Cancer Lett. 304 2011 80 89
109. J. Vrbíková, D. Cibula, K. Dvoráková, S. Stanická, G. Sindelka, M. Hill, M. Fanta, K. Vondra, and J. Skrha Insulin sensitivity in women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 89 2004 2942 2945 (Pubitemid 38766389)
110. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr. Rev. 21 2000 697 738 (Pubitemid 32113289)
111. F. Wang, H. Liu, W.P. Blanton, A. Belkina, N.K. LeBrasseur, and G.V. Denis Brd2 disruption in mice causes severe obesity without Type 2 diabetes Biochem. J. 425 2009 71 83
112. Wang, F., Deeney, J.T., Denis, G.V., in press. Brd2 gene disruption causes 'metabolically healthy' obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from Type 2 diabetes. Vit. Horm. 91, G. Litwack (Ed.), Elsevier Academic Press
113. M.C. Wasko, J. Kay, E.C. Hsia, and M.U. Rahman Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease Arthritis Care Res. (Hoboken) 63 2011 512 521
114. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Invest. 112 2003 1796 1808 (Pubitemid 38063703)
115. S.L. Westlake, A.N. Colebatch, J. Baird, N. Curzen, P. Kiely, M. Quinn, E. Choy, A.J. Ostor, and C.J. Edwards Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: A systematic literature review Rheumatology (Oxford) 50 2011 518 531
116. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053 (Pubitemid 38579764)
117. R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, and M.R. Sowers The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) Arch. Intern. Med. 168 2008 1617 1624
118. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, C.J. Chou, J. Sole, A. Nichols, J.S. Ross, L.A. Tartaglia, and H. Chen Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Invest. 112 2003 1821 1830 (Pubitemid 38063705)
119. B. Xue, S. Sukumaran, J. Nie, W.J. Jusko, D.C. DuBois, and R.R. Almon Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats PLoS ONE 6 2011 e17386
120. E. Yoshihara, S. Fujimoto, N. Inagaki, K. Okawa, S. Masaki, J. Yodoi, and H. Masutani Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity Nat. Commun. 1 2010 127